Multifunctional Cross-Linked Micelles for the Treatment of Acute Pneumonia Caused by MDR-KP with Reduced Cytokine Storms and Restored Metabolism and Immune Balance

Acute pneumonia caused by multidrug-resistant superbugs such as Klebsiella pneumoniae (MDR-KP) poses a severe public health threat for clinical patients with high mortality rate, where excessive cytokine storms and cellular dysfunction are the leading causes of death. More seriously, these superbugs have evolved specialized biological mechanisms that allow them to persist long-term within macrophages, rendering antibiotics and immunomodulators ineffective. Herein, a smart and multifunctional nanomicelle (NAC151-micelle), composed of colistin-NAD+-crosslinked drug and inhibitor H151, is developed for cooperatively killing of MDR-KP bacteria, alleviating hyperinflammatory cytokine storm, and improving metabolism and immune balance. NAC151-micelles optimized through in vitro bactericidal assays can smartly be responsive to the highly reduced environment within infected macrophages, allowing rapid release of active cargoes, including colistin and NAD+, thereby achieving efficient clearance of extra- and intracellular MDR-KP while improving cellular energy metabolism. Meanwhile, co-loaded H151 can cooperatively downregulate key inflammatory pathways of STING-TBK1-IRF3 and NF-κB p65 phosphorylation in macrophages with NAD+, reducing a cytokine storm. In MDR-KP-induced acute pneumonia infection, following intranasal tracheal administration, we observe a targeted accumulation in lung and significant downregulation of MDR-KP burden, together with drastically decreased cytokine storms with good safety. Furthermore, the immune balance in the lung is also greatly improved; pathological tissue injury is effectively repaired; and notably, functional macrophages are essential mediators of their therapeutic efficacy. Collectively, our study presents a safe and multifunctional therapeutic strategy (NAC151-micelles) for acute pneumonia caused by super-bacteria MDR-KP with rapid bacterial clearance, reduced cytokine storms, and improved metabolism and immune balance.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2026-11-09
DOI
https://doi.org/10.1021/acsami.6c17448
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multifunctional Cross-Linked Micelles for the Treatment of Acute Pneumonia Caused by MDR-KP with Reduced Cytokine Storms and Restored Metabolism and Immune Balance

N. H. Song, Xingyue Yang, 正功 刘, Luyue Zhang et al.
ACS Applied Materials & Interfaces
Nanoparticle-Based Drug Delivery
article

Multifunctional Cross-Linked Micelles for the Treatment of Acute Pneumonia Caused by MDR-KP with Reduced Cytokine Storms and Restored Metabolism and Immune Balance

N. H. Song, Xingyue Yang, 正功 刘, Luyue Zhang, Jibo Zhang, Zihan Zhai, Xinna Ma, Meiqi Zhang, Wentao Jiang, Yubao Jin, Ruohan Jiao, Junru Wu
article en

Abstract

Acute pneumonia caused by multidrug-resistant superbugs such as Klebsiella pneumoniae (MDR-KP) poses a severe public health threat for clinical patients with high mortality rate, where excessive cytokine storms and cellular dysfunction are the leading causes of death. More seriously, these superbugs have evolved specialized biological mechanisms that allow them to persist long-term within macrophages, rendering antibiotics and immunomodulators ineffective. Herein, a smart and multifunctional nanomicelle (NAC151-micelle), composed of colistin-NAD+-crosslinked drug and inhibitor H151, is developed for cooperatively killing of MDR-KP bacteria, alleviating hyperinflammatory cytokine storm, and improving metabolism and immune balance. NAC151-micelles optimized through in vitro bactericidal assays can smartly be responsive to the highly reduced environment within infected macrophages, allowing rapid release of active cargoes, including colistin and NAD+, thereby achieving efficient clearance of extra- and intracellular MDR-KP while improving cellular energy metabolism. Meanwhile, co-loaded H151 can cooperatively downregulate key inflammatory pathways of STING-TBK1-IRF3 and NF-κB p65 phosphorylation in macrophages with NAD+, reducing a cytokine storm. In MDR-KP-induced acute pneumonia infection, following intranasal tracheal administration, we observe a targeted accumulation in lung and significant downregulation of MDR-KP burden, together with drastically decreased cytokine storms with good safety. Furthermore, the immune balance in the lung is also greatly improved; pathological tissue injury is effectively repaired; and notably, functional macrophages are essential mediators of their therapeutic efficacy. Collectively, our study presents a safe and multifunctional therapeutic strategy (NAC151-micelles) for acute pneumonia caused by super-bacteria MDR-KP with rapid bacterial clearance, reduced cytokine storms, and improved metabolism and immune balance.

ACS Applied Materials & Interfaces
Xingtai People's Hospital (CN)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon